Naropin 5 mg/ml inj. sol. i.thec. amp. 5 x 10 ml
Active ingredient: Ropivacaine Hydrochloride
View notice details →
News topic
All current shortage notices related to Expected end: 2027-05, structured by product, country, active ingredient and reporting period.
16 noticesActive ingredient: Ropivacaine Hydrochloride
View notice details →Active ingredient: Tadalafil
View notice details →Active ingredient: Tadalafil
View notice details →Active ingredient: Tadalafil
View notice details →Active ingredient: Tadalafil
View notice details →Active ingredient: Tadalafil
View notice details →Active ingredient: Esomeprazole
View notice details →Active ingredient: NATRIUM METHYLPREDNISOLON SUCCINAT
View notice details →Active ingredient: REPAGLINID
View notice details →Active ingredient: REPAGLINID
View notice details →Active ingredient: Esomeprazole
View notice details →Active ingredient: Esomeprazole
View notice details →Active ingredient: SUMATRIPTAN
View notice details →Active ingredient: Esomeprazole
View notice details →Active ingredient: Quetiapine
View notice details →Active ingredient: Golimumab
View notice details →For pharmacies, wholesalers and manufacturers: choose the service matching your operational need.
Researching this shortage professionally? We assess sourcing routes, suppliers and cross-border supply against your requirements. A notice does not confirm stock availability.
Send a sourcing enquiry →Medicine storage, batch and expiry control, picking and distribution for Germany and Europe. We agree the storage profile, temperature and capacity with you.
Request warehouse capacity →